209 related articles for article (PubMed ID: 28901117)
1. [Relationship between calcium overload and myocardial ischemia reperfusion injury and intervention strategy of Chinese herbal medicine].
Li JP; Guo LL; Chen Z; Wang R; Wang J
Zhongguo Zhong Yao Za Zhi; 2016 Jun; 41(11):2168-2173. PubMed ID: 28901117
[TBL] [Abstract][Full Text] [Related]
2. A Strategy for Optimizing the Combination of Active Components Based on Chinese Medicinal Formula Sheng-Mai-San for Myocardial Ischemia.
Li F; Fan XX; Chu C; Zhang Y; Kou JP; Yu BY
Cell Physiol Biochem; 2018; 45(4):1455-1471. PubMed ID: 29466787
[TBL] [Abstract][Full Text] [Related]
3. Dihydropyridine calcium antagonists: beneficial or adverse effects in the setting of myocardial ischaemia/reperfusion?
Ehring T; Heusch G
Cardiology; 1997; 88 Suppl 1():3-14; discussion 15-6. PubMed ID: 9118166
[TBL] [Abstract][Full Text] [Related]
4. Calcium antagonists and experimental myocardial ischemia reperfusion injury.
Ambrosio G; Villari B; Chiariello M
J Cardiovasc Pharmacol; 1992; 20 Suppl 7():S26-9. PubMed ID: 1284153
[TBL] [Abstract][Full Text] [Related]
5. [Thinking on the prevention and treatment of myocardial ischemia/reperfusion injury by Chinese medicine therapy of activating blood circulation and removing stasis].
Hu H; Huang ZD; Zhou DS
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2010 Dec; 30(12):1310-6. PubMed ID: 21302498
[TBL] [Abstract][Full Text] [Related]
6. [Calcium channel antagonists and myocardial ischemia or ischemia/reperfusion].
Lièvre M; Boissel JP
Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():91-8. PubMed ID: 8304818
[TBL] [Abstract][Full Text] [Related]
7. [Progress on research in preventing and treating the myocardial ischemia/reperfussion injury with Chinese herb medicine].
Yi HZ; Wu WK; Hou C
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Aug; 15(8):509-11. PubMed ID: 8580700
[No Abstract] [Full Text] [Related]
8. The pathological mechanisms and potential therapeutic drugs for myocardial ischemia reperfusion injury.
Zhang S; Yan F; Luan F; Chai Y; Li N; Wang YW; Chen ZL; Xu DQ; Tang YP
Phytomedicine; 2024 Jul; 129():155649. PubMed ID: 38653154
[TBL] [Abstract][Full Text] [Related]
9. Protective effect of danshen during myocardial ischemia and reperfusion: an isolated rat heart study.
Zhou W; Ruigrok TJ
Am J Chin Med; 1990; 18(1-2):19-24. PubMed ID: 2239811
[TBL] [Abstract][Full Text] [Related]
10. [Silent myocardial ischemia and its combined therapy of traditional Chinese and Western medicine].
Li J
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1992 Sep; 12(9):548-50. PubMed ID: 1363692
[No Abstract] [Full Text] [Related]
11. Characterization of "hibernating" and "stunned" myocardium with focus on the use of calcium antagonists in "stunned" myocardium.
Ehring T; Schulz R; Heusch G
J Cardiovasc Pharmacol; 1992; 20 Suppl 5():S25-33. PubMed ID: 1282610
[TBL] [Abstract][Full Text] [Related]
12. [Protective effects of Angelica sinensis injection on myocardial ischemia/reperfusion injury in rabbits].
Chen SG; Li CC; Zhuang XX
Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Aug; 15(8):486-8. PubMed ID: 8580698
[TBL] [Abstract][Full Text] [Related]
13. [Regulation of myocardial ischemia reperfusion injury signal pathway by flavonoid monomer].
Hu YQ; Liu JH
Zhongguo Zhong Yao Za Zhi; 2023 Feb; 48(4):879-889. PubMed ID: 36872258
[TBL] [Abstract][Full Text] [Related]
14. Postischemic mechanical and vascular dysfunction (myocardial "stunning" and microvascular "stunning") and the effects of calcium-channel blockers on ischemia/reperfusion injury.
Bolli R; Triana F; Jeroudi MO
Clin Cardiol; 1989 Jul; 12(7 Suppl 3):III16-25. PubMed ID: 2691139
[TBL] [Abstract][Full Text] [Related]
15. Insights into the monomers and single drugs of Chinese herbal medicine on myocardial preservation.
Yuan SM; Jing H
Afr J Tradit Complement Altern Med; 2011; 8(2):104-27. PubMed ID: 22238491
[TBL] [Abstract][Full Text] [Related]
16. Four Main Active Ingredients Derived from a Traditional Chinese Medicine Guanxin Shutong Capsule Cause Cardioprotection during Myocardial Ischemia Injury Calcium Overload Suppression.
Liu F; Huang ZZ; Sun YH; Li T; Yang DH; Xu G; Su YY; Zhang T
Phytother Res; 2017 Mar; 31(3):507-515. PubMed ID: 28164397
[TBL] [Abstract][Full Text] [Related]
17. The calcium antagonist nisoldipine improves the functional recovery of reperfused myocardium only when given before ischemia.
Ehring T; Böhm M; Heusch G
J Cardiovasc Pharmacol; 1992 Jul; 20(1):63-74. PubMed ID: 1383632
[TBL] [Abstract][Full Text] [Related]
18. Antiarrhythmic and anti-ischemic properties of calcium-channel antagonists.
Apostolakos MJ; Varon ME
New Horiz; 1996 Feb; 4(1):45-57. PubMed ID: 8689275
[TBL] [Abstract][Full Text] [Related]
19. [Explore molecular mechanism of Chinese herbs with promoting blood circulation and resolving phlegm effects on myocardial ischemia reperfusion injury based on correlation between microRNA and mtDNA].
Lin F; Chen HW; Shi ZL; Zhao GA; Sun YX
Zhongguo Zhong Yao Za Zhi; 2017 Mar; 42(5):1005-1010. PubMed ID: 28994547
[TBL] [Abstract][Full Text] [Related]
20. Type 2 ryanodine receptor: a novel therapeutic target in myocardial ischemia/reperfusion.
Fauconnier J; Roberge S; Saint N; Lacampagne A
Pharmacol Ther; 2013 Jun; 138(3):323-32. PubMed ID: 23384595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
